Prostate Specific Antigen Levels of Individuals Living in Rural Areas
Launched by SULEYMAN DEMIREL UNIVERSITY · Mar 22, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the levels of a substance called Prostate-Specific Antigen (PSA) in men living in rural areas, with a focus on understanding how these levels relate to prostate cancer. The researchers want to gather information about the participants' health, lifestyle, and PSA test results to better understand the factors that may influence PSA levels in this population.
To participate, men must be at least 55 years old and should not have received any treatment for prostate issues. While the trial is not yet recruiting participants, it aims to help researchers learn more about prostate health in rural communities. If you qualify and decide to join, you will be providing valuable information that could improve understanding and treatment of prostate cancer in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male
- • 55 years or older
- Exclusion Criteria:
- • -Prostate treatment
About Suleyman Demirel University
Suleyman Demirel University is a prominent educational and research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the university collaborates with healthcare professionals and researchers to explore new therapeutic approaches and enhance patient care. Its clinical trial initiatives focus on a range of medical fields, aiming to contribute valuable insights to the scientific community and foster the development of effective treatment strategies. By prioritizing ethical standards and rigorous methodologies, Suleyman Demirel University plays a pivotal role in shaping the future of healthcare through evidence-based research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported